Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 12.63T | 12.69T | 10.60T | 8.42T | 7.86T |
Gross Profit | 1.69T | 2.07T | 1.65T | 1.30T | 995.61B |
EBITDA | 319.44B | 920.40B | 712.35B | 544.22B | 352.73B |
Net Income | -670.90B | 426.65B | 221.90B | 215.53B | -448.70B |
Balance Sheet | |||||
Total Assets | 19.02T | 19.86T | 17.60T | 16.37T | 16.45T |
Cash, Cash Equivalents and Short-Term Investments | 2.20T | 2.02T | 2.01T | 1.79T | 2.03T |
Total Debt | 8.10T | 7.81T | 7.04T | 7.13T | 7.60T |
Total Liabilities | 13.58T | 13.38T | 11.98T | 11.34T | 12.11T |
Stockholders Equity | 4.96T | 5.98T | 5.13T | 4.58T | 3.94T |
Cash Flow | |||||
Free Cash Flow | -624.34B | -666.88B | 87.55B | -276.70B | 140.48B |
Operating Cash Flow | 753.69B | 960.90B | 1.22T | 847.19B | 1.32T |
Investing Cash Flow | -971.23B | -812.66B | -445.39B | -141.52B | -366.24B |
Financing Cash Flow | 263.25B | -131.55B | -670.61B | -1.10T | -642.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $240.18B | 7.81 | 13.36% | 3.02% | 1.06% | -7.05% | |
72 Outperform | $49.61B | 8.26 | 7.07% | 0.96% | 5.34% | -28.29% | |
71 Outperform | $44.06B | 8.88 | 7.11% | 6.78% | 2.72% | -17.58% | |
71 Outperform | $1.04T | 184.76 | 8.43% | ― | -2.73% | -51.64% | |
71 Outperform | $52.55B | 9.31 | 6.54% | 4.38% | 0.83% | -26.70% | |
62 Neutral | $16.51B | 10.46 | -8.28% | 3.32% | 1.44% | -22.58% | |
52 Neutral | $7.37B | 12.38 | -15.23% | 2.76% | -3.87% | -348.81% |